plasma ceramides: advantages over other biomarker tests that predict risk
Published 8 years ago • 317 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:50
dr. scott matherly - liver disease
-
29:26
rapid hyper plex staining and simultaneous imaging for immunophenotyping of tissue sections
-
1:17
hepatitis c is common and treatable
-
0:20
detection of biomarkers..
-
1:24
alltest covid-19 antigen test and fluorescence immunoassay analyzer
-
43:51
bio-markers for hepatocellular carcinoma by lopa mishra, md
-
1:34
serum biochemistry and hematological profile of a cat with three mummified fetuses
-
0:28
science at prbb: xavier estivill's genomics and disease lab (crg)
-
38:48
update on hcv diagnosis and treatment
-
5:54
thawing and plating cryoplateable hepatocytes
-
14:36
hépatitis
-
13:29
ultivue - multiplexed spatial information drives patient stratification
-
2:06
histopathology liver --cryptococcosis
-
1:52
hepatitis c: get tested, get cured.
-
1:29
bispecific bcma-cd3 antibody teclistamab is efficacious and tolerable in r/r mm
-
56:57
cbcovt hepatitis c - a treatable killer virus
-
46:35
james arthos - immuno-pet/ct imaging of virus and cd4 cells in siv infected rhesus macaques treated
-
40:09
hepatitis c virus vertical transmission and the call to egypt: ravi jhaveri
-
4:50
histopathology liver--congenital cytomegalovirus disease